Welcome to LookChem.com Sign In|Join Free
  • or
2-Pyridinecarboxylic acid, 5-(4-nitrophenoxy)-, methyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

284462-65-3

Post Buying Request

284462-65-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

284462-65-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 284462-65-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,8,4,4,6 and 2 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 284462-65:
(8*2)+(7*8)+(6*4)+(5*4)+(4*6)+(3*2)+(2*6)+(1*5)=163
163 % 10 = 3
So 284462-65-3 is a valid CAS Registry Number.

284462-65-3Relevant academic research and scientific papers

Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

-

, (2008/06/13)

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors

-

, (2008/06/13)

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

OMEGA-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS

-

Page/Page column 16, (2010/01/31)

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas

-

, (2008/06/13)

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions in such therapy.

Omega-carboxyaryl subsituted diphenyl ureas as raf kinase inhibitors

-

, (2008/06/13)

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 284462-65-3